| | 147536-97-8 Basic information More.. |
| Product Name: | Bosentan | | Synonyms: | 2’-bipyrimidin)-4-yl)-enoxy)(;benzenesulfonamide,4-(1,1-dimethylethyl)-n-(6-(2-hydroxyethoxy)-5-(2-methoxyph;ro47-0203;4-(tert-Butyl)-N-(6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-[2,2'-bipyrimidin]-4-yl)benzenesulf;Bosentan impurity;Bosentan 13C6;ro47-0203/039;BOSENTAN | | CAS: | 147536-97-8 | | MF: | C27H29N5O6S | | MW: | 551.61 | | EINECS: | 643-099-1 | | Mol File: | 147536-97-8.mol |  |
Use
Bosentan is a mixed endothelin receptor antagonist. Used as a vasodilator. Antihypertensive.
Bosentan is an orally administered, nonselective ET-1 receptor antagonist blocking ETA and ETB receptors and is approved for the treatment of patients with PAH. Following oral administration, bosentan attains peak plasma concentrations in approximately 3 hours, with an absolute bioavailability of approximately 50%. Food has no clinically relevant effect on its absorption recommended doses.
- Bosentan
-
- US $32.00-74.00 / mg
- 2024-11-11
- CAS:147536-97-8
- Min. Order:
- Purity: 99.8%
- Supply Ability: 10g
- Bosentan
-
- US $15.00-10.00 / KG
- 2021-07-13
- CAS:147536-97-8
- Min. Order: 1KG
- Purity: 99%+ HPLC
- Supply Ability: Monthly supply of 1 ton
- Bosentan
-
- US $15.00-10.00 / KG
- 2021-07-09
- CAS:147536-97-8
- Min. Order: 1KG
- Purity: 99%+ HPLC
- Supply Ability: Monthly supply of 1 ton
|
|
147536-97-8
Recommend Suppliers |
|